Candidate Bio
Brian Philippy is known for vocal advocacy, collaboration, volunteer service, and an insistence on regulatory accuracy and evolution. With degrees in Chemistry and Chemical Engineering, Brian is a CEBT with an education rich in analytical and creative thinking. Brian’s eye banking career spans to 1997 – at Lions Gift of Sight and Lions Medical Eye Bank of Eastern Virginia – and includes experience in all technical roles, including at technician, manager, and director levels. Brian also spent 18 years as a Quality Director, while serving a concurrent 7 years as a Consultant and Director of Operations for Vision Share. Marquis expertise in Distribution, Quality, Data Analysis, Procedures/Standards/Regulation, and eye banking microeconomics are hallmarks of Brian’s contributions to eye banking.
Candidate Statement
Having served as an eye banker since before the turn of the century, I’ve been an active part of several revolutions and evolutions during my tenure, including introduction of FDA regulation, DSAEK and DMEK upstart in the U.S., the Cornea Collaborative, introduction of Donor Designation, FDA vs. sepsis and dementia, FDA vs. vCJD, FDA vs. sepsis (round 2) and tuberculosis, HTLV test kit crisis, supply crises, pandemic, melanoma transmission, emerging disease risk assessment, surgical suitability assessment standardization, FDA/EBAA harmonization, and many more events, efforts, and initiatives. My personal platform for Board service is to apply crisis management, creative thinking, and bold strategies to tackle impending challenges and threats, as well as exciting new prospects, to U.S. eye banking that include introduction of cell therapy, accelerating rate of mergers and acquisitions, an ever-expanding array of surgical techniques and eye banking products (proprietary and open-source).
Prior Service
- 2019 – Current – Accreditation Board Forms Subcommittee
- 2012 – Current – Statistical Committee (Chair 2012 – 2022)
- 2012 – Current – Accreditation Board
- 2012 – Current – Medical Advisory Board (Ex-Officio)
- 2025 – 2026 – Tissue Evaluation Requirement Subcommittee
- 2025 – 2026 – Specular Microscopy Subcommittee
- 2017 – 2022 – Ocular Network Exchange Advisory Board
- 2020 – 2022 – Policy & Position Review Subcommittee
- 2016 – 2017, 2020 – 2022 – EBAA Board of Directors
- 2020 – 2021 – Adverse Reaction Investigation and Reporting Subcommittee
- 2017 – 2019 – Tissue Evaluation & Surgical Suitability Subcommittee
- 2017 – 2019 – Accreditation Board Modernizing Inspections Subcommittee
- 2016 – International Accreditation Subcommittee
- 2016 – Melanoma Eligibility Subcommittee
- 2015 – 2029 – ISBT 128 Subcommittee
- 2015 – Tissue Report Form Subcommittee
- 2015 – Globalization of Medical Standards Subcommittee
- 2011 – 2012 – Harmonization of EBAA Medical Standards, Procedures, Accreditation, and Bylaws Subcommittee
- 2012 – 2014 – Quality Assurance Committee
- 2009 – 2010 – Statistical Report Taskforce
- 2009 – 2010 – Harmonization of FDA & EBAA Eligibility Criteria Subcommittee
- 2008 – 2010 – Exam Committee
- 2008 – 2010 – Cornea Collaborative Faculty
- 2008 – 2010 – Cornea Collaborative Statistics Subcommittee
- 2007 – 2017 – Uniform Donor History Questionnaire Taskforce
- 2006 – 2008 – Technical Procedures Manual Subcommittee
